On the public citation graph

Which Agent is the Best Tace Agent for Patients with Different Nlr Hepatocellular Carcinomas? A Systematic Review and Network Meta-Analysis

https://doi.org/10.2139/ssrn.4647890
0 signed · 54 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/14651858.ed000142openalex-extracted
Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions
inferredcites →https://doi.org/10.1007/s00261-020-02612-5openalex-extracted
Transarterial chemoembolization combined with radiofrequency ablation for solitary large hepatocellular carcinoma ranging from 5 to 7 cm: an 8-year prospective study
inferredcites →https://doi.org/10.1016/j.ctrv.2018.11.002openalex-extracted
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
inferredcites →https://doi.org/10.1016/j.eclinm.2021.101213openalex-extracted
Association of glucagon-like peptide 1 analogs and agonists administered for obesity with weight loss and adverse events: a systematic review and network meta-analysis
inferredcites →https://doi.org/10.1016/j.eclinm.2022.101747openalex-extracted
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data
inferredcites →https://doi.org/10.1016/j.eclinm.2023.101964openalex-extracted
Prevalence of locoregional recurrence and survival post-treatment of head and neck cancers in Africa: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.ejca.2018.07.131openalex-extracted
A meta-analysis assessing the survival implications of subclassifying T3 rectal tumours
inferredcites →https://doi.org/10.1016/j.ejso.2007.02.014openalex-extracted
Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases
inferredcites →https://doi.org/10.1016/j.jhep.2021.11.018openalex-extracted
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
inferredcites →https://doi.org/10.1016/j.jimed.2023.03.001openalex-extracted
Optimal interventional treatment for liver cancer: HAIC, TACE or iTACE?
inferredcites →https://doi.org/10.1016/j.jvir.2010.12.041openalex-extracted
Blood Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
inferredcites →https://doi.org/10.1016/j.jvir.2019.08.001openalex-extracted
Neutrophil/Lymphocyte Ratio Predicts Increased Risk of Immediate Progressive Disease following Chemoembolization of Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1016/j.phrs.2018.06.021openalex-extracted
Which is the best combination of TACE and Sorafenib for advanced hepatocellular carcinoma treatment? A systematic review and network meta-analysis
inferredcites →https://doi.org/10.1016/j.trsl.2012.01.011openalex-extracted
An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/s0016-5085(20)34169-xopenalex-extracted
Mo1415 PROGNOSTIC SIGNIFICANCE OF NEUTROPHIL-TO-LYMPHOCYTE AND LYMPHOCYTE-TO-MONOCYTE RATIOS IN PATIENTS UNDERGOING TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
inferredcites →https://doi.org/10.1038/s41598-017-13239-wopenalex-extracted
Neutrophil-lymphocyte Ratio Plus Prognostic Nutritional Index Predicts the Outcomes of Patients with Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization
inferredcites →https://doi.org/10.1055/s-0038-1641646openalex-extracted
Neutrophil-to-Lymphocyte and Aspartate-to-Alanine Aminotransferase Ratios Predict Hepatocellular Carcinoma Prognosis after Transarterial Embolization
inferredcites →https://doi.org/10.1055/s-0038-1641647openalex-extracted
Prognostic Value of Inflammation Scores in Liver Cancer Post Transarterial Chemoembolization
inferredcites →https://doi.org/10.1080/07357907.2022.2065508openalex-extracted
Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma after Transarterial Chemoembolization Combined With Radiofrequency Ablation
inferredcites →https://doi.org/10.1089/jayao.2019.0046openalex-extracted
Using Pre-Treatment Neutrophil-to-Lymphocyte Ratio to Predict the Prognosis of Young Patients with Hepatocellular Carcinoma Implemented Minimally Invasive Treatment
inferredcites →https://doi.org/10.1097/cad.0000000000001458openalex-extracted
Neutrophil-to-lymphocyte ratio predicts therapy outcomes of transarterial chemoembolization combined with tyrosine kinase inhibitors plus programmed cell death ligand 1 antibody for unresectable hepatocellular carcinoma
inferredcites →https://doi.org/10.1097/md.0000000000008512openalex-extracted
Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization
inferredcites →https://doi.org/10.1097/meg.0000000000001629openalex-extracted
Neutrophil-lymphocyte ratio predicts the therapeutic benefit of neoadjuvant transarterial chemoembolization in patients with resectable hepatocellular carcinoma
inferredcites →https://doi.org/10.1111/liv.15251openalex-extracted
Changing epidemiology of hepatocellular carcinoma in Asia
inferredcites →https://doi.org/10.1136/bmj.b2700openalex-extracted
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
inferredcites →https://doi.org/10.1148/radiol.2241011262openalex-extracted
Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled Trials
inferredcites →https://doi.org/10.1155/2017/4164130openalex-extracted
Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
inferredcites →https://doi.org/10.12659/msm.929879openalex-extracted
Factors Associated with Recurrence of Hepatocellular Carcinoma in 197 Patients Following Transarterial Chemoembolization: A Retrospective Study from a Single Center
inferredcites →https://doi.org/10.1371/journal.pone.0119312openalex-extracted
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Survival and Metastasis for Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization
inferredcites →https://doi.org/10.1371/journal.pone.0230879openalex-extracted
Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis
inferredcites →https://doi.org/10.14218/jcth.2022.00293openalex-extracted
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
inferredcites →https://doi.org/10.15537/smj.2020.4.24911openalex-extracted
A combination of the preoperative neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios as a useful predictor of survival outcomes following the transarterial chemoembolization of huge hepatocellular carcinoma
inferredcites →https://doi.org/10.1590/s1677-5538.ibju.2017.03.02openalex-extracted
PRISMA statement and PROSPERO
inferredcites →https://doi.org/10.21037/18166openalex-extracted
inferredcites →https://doi.org/10.21037/atm.2020.02.113openalex-extracted
The neutrophil-to-lymphocyte ratio is a predictive factor for the survival of patients with hepatocellular carcinoma undergoing transarterial chemoembolization
inferredcites →https://doi.org/10.21037/tcr.2017.12.24openalex-extracted
Neutrophil to lymphocyte ratio but not ring enhancement could predict treatment response and new lesion occurrence in patients with hepatocellular carcinoma by drug eluting beads transarterial chemoembolization
inferredcites →https://doi.org/10.21037/tcr.2019.10.18openalex-extracted
Systemic inflammatory response predicts poor prognoses in Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma with transarterial chemoembolization: a prospective study
inferredcites →https://doi.org/10.2147/cmar.s190545openalex-extracted
The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy
inferredcites →https://doi.org/10.2147/cmar.s245396openalex-extracted
Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
inferredcites →https://doi.org/10.2147/jhc.s335183openalex-extracted
Inflammatory Scores: Comparison and Utility in HCC Patients Undergoing Transarterial Chemoembolization in a North American Cohort
inferredcites →https://doi.org/10.2147/jhc.s393964openalex-extracted
Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment
inferredcites →https://doi.org/10.2147/ott.s217935openalex-extracted
Prognostic significance of lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization and radiofrequency ablation
inferredcites →https://doi.org/10.3389/fimmu.2022.1060051openalex-extracted
Prognostic model of immune checkpoint inhibitors combined with anti-angiogenic agents in unresectable hepatocellular carcinoma
inferredcites →https://doi.org/10.3389/fmolb.2021.624366openalex-extracted
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib
inferredcites →https://doi.org/10.3389/fonc.2022.1029951openalex-extracted
Prognostic efficacy and prognostic factors of TACE plus TKI with ICIs for the treatment of unresectable hepatocellular carcinoma: A retrospective study
inferredcites →https://doi.org/10.3390/cancers11040509openalex-extracted
Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
inferredcites →https://doi.org/10.3390/cancers13112830openalex-extracted
Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma
inferredcites →https://doi.org/10.3390/curroncol30030267openalex-extracted
CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE
inferredcites →https://doi.org/10.3390/diagnostics12051170openalex-extracted
Prognostic Values of Inflammation-Based Scores and Fibrosis Markers in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
inferredcites →https://doi.org/10.3748/wjg.v23.i20.3690openalex-extracted
Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation
inferredcites →https://doi.org/10.3760/cma.j.issn.0366-6999.20141234openalex-extracted
Prognostic significance of neutrophil to lymphocyte ratio in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
inferredcites →https://doi.org/10.3760/cma.j.issn.1005-1201.2015.10.011openalex-extracted
Preoperative neutrophil-lymphocyte ratio as a prognostic predictor after transarterial chemoembolization for HBV-associated hepatocellular carcinoma
inferredcites →https://doi.org/10.3892/ol.2014.1896openalex-extracted
Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in non-viral hepatocellular carcinoma treated with transarterial chemoembolization
inferredcites →https://doi.org/10.3892/ol.2016.4359openalex-extracted
Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.